Literature DB >> 19877732

Candidaemia in patients with an inserted medical device.

Roberto Cauda1.   

Abstract

The importance of medical devices as a source of infection has been increasingly appreciated. Candida spp. are responsible for a significantly increasing number of device-related infections, particularly those involving the bloodstream and urinary tract. A wide range of devices may be colonized by Candida spp., including central venous catheters, cardiac devices, and knee and hip prostheses. Medical device infections invariably require antifungal therapy and, in many cases, device removal, with associated hazards to some patients. Currently recommended treatments include amphotericin B formulations, azoles and echinocandins. The echinocandins, with efficacy against Candida biofilms, may have a role in the future in improved lock therapy for the treatment of device-associated candidal infections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19877732     DOI: 10.2165/11315520-000000000-00000

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  19 in total

1.  Candiduria.

Authors:  Carol A Kauffman
Journal:  Clin Infect Dis       Date:  2005-09-15       Impact factor: 9.079

2.  Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms.

Authors:  Aspasia Katragkou; Athanasios Chatzimoschou; Maria Simitsopoulou; Maria Dalakiouridou; Eudoxia Diza-Mataftsi; Chaido Tsantali; Emmanuel Roilides
Journal:  Antimicrob Agents Chemother       Date:  2007-10-15       Impact factor: 5.191

Review 3.  Intravascular catheter-related infections: advances in diagnosis, prevention, and management.

Authors:  Issam Raad; Hend Hanna; Dennis Maki
Journal:  Lancet Infect Dis       Date:  2007-10       Impact factor: 25.071

4.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

Authors:  Leonard A Mermel; Michael Allon; Emilio Bouza; Donald E Craven; Patricia Flynn; Naomi P O'Grady; Issam I Raad; Bart J A Rijnders; Robert J Sherertz; David K Warren
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

5.  Resistance of Candida albicans biofilms to antifungal agents in vitro.

Authors:  S P Hawser; L J Douglas
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

Review 6.  Candida cerebrospinal fluid shunt infection. Report of two new cases and review of the literature.

Authors:  J Sánchez-Portocarrero; P Martín-Rabadán; C J Saldaña; E Pérez-Cecilia
Journal:  Diagn Microbiol Infect Dis       Date:  1994-09       Impact factor: 2.803

7.  In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies.

Authors:  Gordon Ramage; Kacy VandeWalle; Stefano P Bachmann; Brian L Wickes; José L López-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

Review 8.  Candida infections of medical devices.

Authors:  Erna M Kojic; Rabih O Darouiche
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

9.  Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections.

Authors:  Muhammad R Sohail; Daniel Z Uslan; Akbar H Khan; Paul A Friedman; David L Hayes; Walter R Wilson; James M Steckelberg; Sarah Stoner; Larry M Baddour
Journal:  J Am Coll Cardiol       Date:  2007-04-23       Impact factor: 24.094

10.  In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth.

Authors:  Estelle Cateau; Marie-Hélène Rodier; Christine Imbert
Journal:  J Antimicrob Chemother       Date:  2008-04-10       Impact factor: 5.790

View more
  21 in total

Review 1.  Candida albicans Biofilms and Human Disease.

Authors:  Clarissa J Nobile; Alexander D Johnson
Journal:  Annu Rev Microbiol       Date:  2015       Impact factor: 15.500

2.  Conclusions. Anidulafungin is a new echinocandin developed for more effective treatment of serious systemic fungal infections.

Authors:  Pasquale De Bellis
Journal:  Drugs       Date:  2009       Impact factor: 9.546

3.  Polymer multilayers loaded with antifungal β-peptides kill planktonic Candida albicans and reduce formation of fungal biofilms on the surfaces of flexible catheter tubes.

Authors:  Namrata Raman; Myung-Ryul Lee; Sean P Palecek; David M Lynn
Journal:  J Control Release       Date:  2014-05-24       Impact factor: 9.776

4.  Human serum potentiates the expression of genes associated with antifungal drug resistance in C. albicans biofilms on central venous catheters.

Authors:  L P Samaranayake; S Anil; M Hashem; S Vellappally; B P K Cheung
Journal:  Mycopathologia       Date:  2014-12-17       Impact factor: 2.574

5.  Usefulness of McRAPD for typing and importance of biofilm production in a case of nosocomial ventriculoperitoneal shunt infection caused by Candida lusitaniae.

Authors:  Petr Hamal; Juraj Hanzen; Frantisek Horn; Jitka Trtkova; Lenka Ruskova; Renata Vecerova; Filip Ruzicka; Anna Vollekova; Vladislav Raclavsky
Journal:  Folia Microbiol (Praha)       Date:  2011-09-06       Impact factor: 2.099

Review 6.  Intestinal Infection of Candida albicans: Preventing the Formation of Biofilm by C. albicans and Protecting the Intestinal Epithelial Barrier.

Authors:  Ziyao Peng; Jianguo Tang
Journal:  Front Microbiol       Date:  2022-02-02       Impact factor: 5.640

7.  Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates.

Authors:  Maria Simitsopoulou; Pavla Peshkova; Efthymia Tasina; Aspasia Katragkou; Daniela Kyrpitzi; Aristea Velegraki; Thomas J Walsh; Emmanuel Roilides
Journal:  Antimicrob Agents Chemother       Date:  2013-03-25       Impact factor: 5.191

8.  Combination of Miconazole and Domiphen Bromide Is Fungicidal against Biofilms of Resistant Candida spp.

Authors:  Jana Tits; Freya Cools; Kaat De Cremer; Katrijn De Brucker; Judith Berman; Kristof Verbruggen; Bert Gevaert; Paul Cos; Bruno P A Cammue; Karin Thevissen
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

Review 9.  Ras signaling gets fine-tuned: regulation of multiple pathogenic traits of Candida albicans.

Authors:  Diane O Inglis; Gavin Sherlock
Journal:  Eukaryot Cell       Date:  2013-08-02

10.  Inhibitory Effect of 5-Aminoimidazole-4-Carbohydrazonamides Derivatives Against Candida spp. Biofilm on Nanohydroxyapatite Substrate.

Authors:  C Gabriel; L Grenho; F Cerqueira; R Medeiros; A M Dias; A I Ribeiro; M F Proença; M H Fernandes; J C Sousa; F J Monteiro; M P Ferraz
Journal:  Mycopathologia       Date:  2019-11-02       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.